Lucid Diagnostics Inc (NASDAQ:LUCD)’s traded shares stood at 0.43 million during the latest session, with the company’s beta value hitting 1.28.The LUCD share’s 52-week high
In last trading session, Lucid Diagnostics Inc (NASDAQ:LUCD) saw 1.01 million shares changing hands with its beta currently measuring 1.34. Company’s recent per share price
During the last session, Lucid Diagnostics Inc (NASDAQ:LUCD)’s traded shares were 1.33 million, with the beta value of the company hitting 1.35. At the end
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
